Patent application number | Description | Published |
20100016248 | TABLET FORMULATION - The invention relates to a tablet formulated for administration to an animal to treat parasite infestation. The tablet includes at least one macrocyclic lactone compound with anthelmintic activity dissolved in at least one organic solvent and subsequently formulated into a tablet. The tablets produced have a high degree of stability when stored over time and also provide the animal with a dose of agent sufficient to be therapeutically effective. | 01-21-2010 |
20100137389 | TOPICAL FORMULATION - The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy. | 06-03-2010 |
20120022038 | ANIMAL TREATMENT FORMULATION AND METHODS OF USE - The present invention relates to a formulation for administration to the teat canal of the mammary gland of an animal, the formulation including: a physical barrier material, characterised in that the formulation includes sufficient antibiotic in relation to physical barrier material such that the formulation is configured to disintegrate over a period of time after administration to the teat canal. | 01-26-2012 |
20140221299 | ANTI-PARASITIC COMPOSITION COMPRISING A MACROCYCLIC LACTONE AND LEVAMISOLE AND METHOD OF TREATMENT OF PARASITIC INFESTATION - This invention relates to a veterinary antiparasitic solubilised composition including a macrocyclic lactone or a pharmaceutically equivalent salt thereof, and levamisole or a pharmaceutically equivalent salt thereof, characterised in that the pH of the composition is in the range of 2.0 to 5.0 and wherein the composition includes at least one surfactant and at least one antioxidant. | 08-07-2014 |
20150045337 | CONTROLLED RELEASE COMPOSITIONS AND THEIR METHODS OF USE - The present invention relates to a composition, the composition including a therapeutically effective amount of at least one active agent, and a base including, an amount of colloidal silica; at least one oil; and at least one surfactant, wherein the viscosity of the composition is below 1000 mPas at a shear rate of 100 l/s and at a temperature of 20° C. | 02-12-2015 |
20150150854 | INJECTABLE ANTIBIOTIC FORMULATIONS AND THEIR METHODS OF USE - This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and triacetin. | 06-04-2015 |
20150174248 | INJECTABLE ANTIBIOTIC FORMULATIONS AND THEIR METHODS OF USE - This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and at least one oily vehicle. | 06-25-2015 |